Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Statins Kill Acute Myeloid Leukemia Cells through Low-Density Lipoprotein Receptor-Mediated Unfolded Protein Response Activation

Yohei Yasuda, Yuta Fukui, Ken Morita, Muzhapaer Mubalizi, Hiroki Hayashida, Toshiya Hino, Yosuke Masamoto, Mineo Kurokawa

Blood (2024) 144 (Supplement 1): 4148.

https://doi.org/10.1182/blood-2024-198761

Published: 2024

Journal Articles

ETV6 Contributes to Maintenance of Leukemia Stem Cells in Acute Myeloid Leukemia with High EVI1 Expression

Toshiya Hino, Yosuke Masamoto, Ken Morita, Hiroki Hayashida, Mineo Kurokawa

Blood (2024) 144 (Supplement 1): 2725.

https://doi.org/10.1182/blood-2024-201987

Published: 2024

Journal Articles

Identification of ZFP91 As the Master Transcription Factor for EVI1 Gene Expression

Hiroki Hayashida, Toshiya Hino, Ken Morita, Yosuke Masamoto, Mineo Kurokawa

Blood (2023) 142 (Supplement 1): 2744.

https://doi.org/10.1182/blood-2023-174305

Published: 2023

Journal Articles

EVI1 Promotes Immune-Evasive Microenvironment Via Cyclin D1 in Acute Myeloid Leukemia

Yosuke Masamoto, Akira Chiba, Toshiya Hino, Hiroki Hayashida, Hideaki Mizuno, Tomohiko Sato, Mineo Kurokawa

Blood (2022) 140 (Supplement 1): 85–86.

https://doi.org/10.1182/blood-2022-158107

Published: 2022

Journal Articles

EVI1-Positive AML Cells Show Distinct Features and High Dependency on ETS Transcription Factor ERG

Yosuke Masamoto, Akira Chiba, Toshiaki Takezaki, Toshiya Hino, Hiroki Hayashida, Hideaki Mizuno, Tomohiko Sato, Mineo Kurokawa

Blood (2021) 138 (Supplement 1): 784.

https://doi.org/10.1182/blood-2021-149015

Published: 2021

Journal Articles

Prognostic Impact of Time from Diagnosis to Initial Chemotherapy for Acute Myeloid Leukemia

Yoshimasa Kamoda, MD, Akira Hangaishi, MD PhD, Hiroki Hayashida, MD, Yusuke Uchibori, MD, Hiromitsu Iizuka, MD PhD, Michiko Kida, MD PhD, Kensuke Usuki, MD PhD

Blood (2018) 132 (Supplement 1): 3981.

https://doi.org/10.1182/blood-2018-99-111123

Published: 2018

NARROW

Statins Kill Acute Myeloid Leukemia Cells through Low-Density Lipoprotein Receptor-Mediated Unfolded Protein Response Activation

ETV6 Contributes to Maintenance of Leukemia Stem Cells in Acute Myeloid Leukemia with High EVI1 Expression

Identification of ZFP91 As the Master Transcription Factor for EVI1 Gene Expression

EVI1 Promotes Immune-Evasive Microenvironment Via Cyclin D1 in Acute Myeloid Leukemia

EVI1-Positive AML Cells Show Distinct Features and High Dependency on ETS Transcription Factor ERG

Prognostic Impact of Time from Diagnosis to Initial Chemotherapy for Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Statins Kill Acute Myeloid Leukemia Cells through Low-Density Lipoprotein Receptor-Mediated Unfolded Protein Response Activation

ETV6 Contributes to Maintenance of Leukemia Stem Cells in Acute Myeloid Leukemia with High EVI1 Expression

Identification of ZFP91 As the Master Transcription Factor for EVI1 Gene Expression

EVI1 Promotes Immune-Evasive Microenvironment Via Cyclin D1 in Acute Myeloid Leukemia

EVI1-Positive AML Cells Show Distinct Features and High Dependency on ETS Transcription Factor ERG

Prognostic Impact of Time from Diagnosis to Initial Chemotherapy for Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only